Parathyroid hormone analog (peptide fragment)
Teriparatide
Brand names: Forteo, Bonsity
Last reviewed 2026-08-01
Women-specific evidencePregnancy/lactation data limited
Teriparatide is approved for osteoporosis in postmenopausal women. Reproductive labeling and fracture-risk counseling should follow current regulatory labels.
Key takeaways
- Approved for osteoporosis in postmenopausal women and men at high fracture risk.
- Pregnancy and lactation labeling should be reviewed directly.
Medical disclaimer: Her Health Peptides publishes educational, source-linked summaries. We do not provide individualized medical advice, diagnosis, or treatment recommendations. Always talk with a licensed clinician about your specific situation, especially if you are pregnant, breastfeeding, planning pregnancy, or taking other medicines.